Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

French Prospective Randomised Double Blind Study, on Aspirin Versus Placebo in Resected Colon Cancer With PI3K Mutation

NCT02945033 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT02945033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02945033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
French Prospective Randomised Double Blind Study, on Aspirin Versus Placebo in Resected Colon Cancer With PI3K Mutation
Lead sponsor
University Hospital, Rouen
Phase
Phase 3
Overall status
Active, not recruiting
Start date
July 12, 2018
Completion date
July 31, 2028
Enrollment
264 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer